Osimertinib: Revision history

7 April 2024

• curprev 05:4705:47, 7 April 2024‎ Whywhenwhohow talk contribs‎ 17,390 bytes +300‎ add ref undo

24 March 2024

• curprev 06:4106:41, 24 March 2024‎ Whywhenwhohow talk contribs‎ 17,090 bytes +383‎ update infobox undo

9 March 2024

• curprev 04:0604:06, 9 March 2024‎ Whywhenwhohow talk contribs‎ 16,707 bytes +980‎ update history, cats, templates undo

27 February 2024

• curprev 07:1907:19, 27 February 2024‎ Whywhenwhohow talk contribs‎ m 15,727 bytes +64‎ script-assisted date audit and style fixes per MOS:NUM undo
• curprev 07:1907:19, 27 February 2024‎ Whywhenwhohow talk contribs‎ 15,663 bytes −202‎ add US indication; remove text wrong audience; update links undo

20 December 2023

• curprev 19:2319:23, 20 December 2023‎ JJMC89 bot III talk contribs‎ m 15,865 bytes +12‎ Moving Category:AstraZeneca brands to Category:Drugs developed by AstraZeneca per Wikipedia:Categories for discussion/Log/2023 December 9#Category:AstraZeneca brands undo

12 December 2023

• curprev 11:4611:46, 12 December 2023‎ JJMC89 bot III talk contribs‎ m 15,853 bytes −34‎ Removing Category:Breakthrough therapy per Wikipedia:Categories for discussion/Log/2023 November 20#Category:Breakthrough therapy undo

12 September 2023

• curprev 08:3908:39, 12 September 2023‎ Materialscientist talk contribs‎ m 15,887 bytes −10‎ Reverted edits by 182.160.117.201 (talk): not providing a reliable source (WP:CITE, WP:RS) (HG) (3.4.12) undo Tags: Huggle Rollback
• curprev 08:3808:38, 12 September 2023‎ 182.160.117.201 talk‎ 15,897 bytes +10‎ No edit summary undo Tag: Reverted

19 July 2023

• curprev 00:3100:31, 19 July 2023‎ BD2412 talk contribs‎ m 15,887 bytes +5‎ Clean up spacing errors around ref tags., replaced: /ref>T → /ref> T undo Tag: AWB

13 April 2023

• curprev 04:3304:33, 13 April 2023‎ Boghog talk contribs‎ 15,882 bytes −251‎ consistent citation formatting undo

12 April 2023

• curprev 21:1521:15, 12 April 2023‎ Ira Leviton talk contribs‎ 16,133 bytes −10‎ Fixed a PMC parameter in a citation and deleted an unneeded jargon abbreviation. Please see Category:CS1 maint: PMC format. undo
• curprev 21:0921:09, 12 April 2023‎ Airdocphd talk contribs‎ 16,143 bytes +710‎ Added new study undo Tag: Visual edit

10 April 2023

• curprev 07:1807:18, 10 April 2023‎ Whywhenwhohow talk contribs‎ 15,433 bytes +333‎ →‎top: add ref undo

11 March 2023

• curprev 20:5720:57, 11 March 2023‎ Citation bot talk contribs‎ 15,100 bytes +25‎ Add: date. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 1336/2056 undo

28 November 2022

• curprev 19:4319:43, 28 November 2022‎ Citation bot talk contribs‎ 15,075 bytes +20‎ Add: s2cid. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 3247/3439 undo

23 October 2022

• curprev 19:2119:21, 23 October 2022‎ CV9933 talk contribs‎ 15,055 bytes +654‎ Expand and cite, also deprecated parameter -used template lay source. undo

23 May 2022

• curprev 18:2718:27, 23 May 2022‎ Gbyrnewiki talk contribs‎ m 14,401 bytes −25‎ →‎Pharmacology: re-worded the type of mutant EGFR to which osimertinib binds, and added the word preferentially since it does bind wild-type (not mutant) EGFR, just with lower affinity. undo
• curprev 18:2118:21, 23 May 2022‎ Gbyrnewiki talk contribs‎ m 14,426 bytes −36‎ →‎Medical uses: made it clearer that Foundation CDx is one of many available companion diagnostics used to test for EGFR mutations. undo
• curprev 18:1818:18, 23 May 2022‎ Gbyrnewiki talk contribs‎ m 14,462 bytes +21‎ →‎Economics: added specificity of "in the United States" to osimertinib initial cost undo
• curprev 18:1418:14, 23 May 2022‎ Gbyrnewiki talk contribs‎ m 14,441 bytes +5‎ →‎Medical uses: added EGFR for specificity (there are many classes of tyrosine kinase inhibitors) undo
• curprev 18:1318:13, 23 May 2022‎ Gbyrnewiki talk contribs‎ m 14,436 bytes +16‎ →‎Medical uses: added erlotinib ( a common 1st generation EGFR TKI) undo

18 May 2022

• curprev 13:5813:58, 18 May 2022‎ Anypodetos talk contribs‎ m 14,420 bytes −85‎ Reverted edits by Nayeemsarker2022 (talk) to last version by Whywhenwhohow undo Tag: Rollback
• curprev 09:2909:29, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ m 14,505 bytes +6‎ No edit summary undo Tag: Reverted
• curprev 09:2709:27, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ 14,499 bytes +4‎ No edit summary undo Tag: Reverted
• curprev 09:0709:07, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ 14,495 bytes −4‎ No edit summary undo Tag: Reverted
• curprev 09:0209:02, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ m 14,499 bytes −6‎ No edit summary undo Tag: Reverted
• curprev 08:5908:59, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ 14,505 bytes −39‎ No edit summary undo Tag: Reverted
• curprev 08:5708:57, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ 14,544 bytes +76‎ No edit summary undo Tag: Reverted
• curprev 08:5508:55, 18 May 2022‎ Nayeemsarker2022 talk contribs‎ m 14,468 bytes +48‎ No edit summary undo Tag: Reverted

11 April 2022

• curprev 00:3000:30, 11 April 2022‎ Whywhenwhohow talk contribs‎ 14,420 bytes +16‎ add template undo

18 March 2022

• curprev 14:2514:25, 18 March 2022‎ Esprit15d talk contribs‎ 14,404 bytes −15‎ fixed 4x extra whitespace in citation ( url=), 3x extra whitespace in citation ( url = ), 3x extra whitespace in citation (url =), 3x extra whitespace in citation (url= ), 2x invalid ref position using ARA undo

17 February 2022

• curprev 15:5915:59, 17 February 2022‎ 136.158.33.143 talk‎ 14,419 bytes −11‎ use canonicalized SMILES undo

23 July 2021

• curprev 15:5515:55, 23 July 2021‎ 74.104.188.30 talk‎ 14,430 bytes +1‎ →‎Pharmacology: article agreement undo

2 July 2021

• curprev 10:5310:53, 2 July 2021‎ Rodw talk contribs‎ m 14,429 bytes +5‎ Disambiguating links to Cmax (link changed to CMax) using DisamAssist. undo

27 June 2021

• curprev 01:2201:22, 27 June 2021‎ 173.48.18.201 talk‎ 14,424 bytes +4‎ →‎Pharmacology: link undo
• curprev 01:0701:07, 27 June 2021‎ 173.48.18.201 talk‎ 14,420 bytes +4‎ →‎Pharmacology: link undo

14 May 2021

• curprev 07:0607:06, 14 May 2021‎ Anypodetos talk contribs‎ 14,416 bytes −9‎ Undid revision 1022964791 by 103.67.157.201 (talk) Only primary trade names per MOS:MED undo Tag: Manual revert

13 May 2021

• curprev 14:4314:43, 13 May 2021‎ 103.67.157.201 talk‎ 14,425 bytes 0‎ No edit summary undo Tags: Reverted Mobile edit Mobile web edit

20 April 2021

• curprev 05:3305:33, 20 April 2021‎ Onlinemedicalwriting talk contribs‎ m 14,425 bytes +9‎ No edit summary undo Tag: Reverted

18 April 2021

• curprev 08:4608:46, 18 April 2021‎ Anypodetos talk contribs‎ 14,416 bytes −9‎ →‎top: Trim non-primary brands per MOS:MED#Drugs, treatments, and devices and MOS:PHARM undo

17 April 2021

• curprev 18:0818:08, 17 April 2021‎ 103.56.5.54 talk‎ 14,425 bytes +9‎ Irmukin is the brand of generic Osimertinib, manufacturing by Genvio Pharma Limited. Irmukin is available as 80 mg orally used tablet in alu-alu blister pack. undo

2 January 2021

• curprev 08:1508:15, 2 January 2021‎ Whywhenwhohow talk contribs‎ 14,416 bytes −34‎ update infobox undo

25 December 2020

• curprev 19:1619:16, 25 December 2020‎ Qwfp talk contribs‎ 14,450 bytes +4‎ →‎Society and culture: Added links undo Tags: Mobile edit Mobile app edit Android app edit

21 December 2020

• curprev 09:0609:06, 21 December 2020‎ Whywhenwhohow talk contribs‎ 14,446 bytes +492‎ add side effects undo
• curprev 08:5908:59, 21 December 2020‎ Whywhenwhohow talk contribs‎ 13,954 bytes −2‎ MOS:REFPUNC undo Tag: Manual revert

18 December 2020

• curprev 07:0707:07, 18 December 2020‎ 2409:4050:2d16:8cee::5cc8:c605 talk‎ 13,956 bytes −247‎ →‎Osimertinib undo Tags: Reverted references removed Mobile edit Mobile app edit Android app edit
• curprev 07:0407:04, 18 December 2020‎ 2409:4050:2d16:8cee::5cc8:c605 talk‎ 14,203 bytes +11‎ →‎Osimertinib undo Tags: Reverted Mobile edit Mobile app edit Android app edit
• curprev 06:5906:59, 18 December 2020‎ 2409:4050:2d16:8cee::5cc8:c605 talk‎ 14,192 bytes +238‎ →‎Osimertinib undo Tags: Reverted Mobile edit Mobile app edit Android app edit

15 November 2020

• curprev 05:2705:27, 15 November 2020‎ Redthreadhx talk contribs‎ m 13,954 bytes 0‎ →‎Economics undo